Pharmaceuticals Company Reports
Pharmaceuticals companies are involved into development, production as well as marketing of an extensive variety of medicines. The pharmaceuticals industry is represented by innumerable companies. Small biotechnology and biopharmaceutical manufacturers, mid-sized specialty companies, large multi-nationals enterprises are amid the world pharma companies.
Appearance of new products; introduction of new product costs structures and modes of healthcare delivery; modification of product cost, offerings and design; growing public scrutiny; scientific researches in the fields of nanotechnology, bioengineering, etc. are among trends contributing to changes in the pharmaceutical industry.
Johnson & Johnson, Pfizer, Inc., Roche Holding AG, Novartis International AG, Abbott Laboratories, etc. are amid behemoths of the pharmaceutical industry.
Within this MarketPublishers’ catalogue there are innumerable reports featuring pharmaceutical companies’ overviews. The research reports provide a state-of-the-art picture of the pharma market including the analyses of the pharmaceuticals companies. Evaluation of companies’ strategies and data on products offerings are available in the research studies.
... and featured press releases, both from Zensun (Shanghai) Sci & Tech Co., Ltd. and industry-specific third party sources, put together ... facts, and its locations and subsidiaries. Review of current pipeline of Zensun (Shanghai) Sci & Tech Co., Ltd. human therapeutic division. Overview of pipeline therapeutics ...
May, 2013 29 pages... reviews key players involved in the therapeutic development for Warts. Warts - Pipeline Review, Half Year is built using data and information sourced ... on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. Identify ...
May, 2013 60 pages... key players involved in the therapeutic development for Vascular Dysfunction. Vascular Dysfunction - Pipeline Review, Half Year is built using data and ... on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. Identify ...
May, 2013 41 pagesTiGenix NV – Product Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “TiGenix NV - Product Pipeline Review - 2013” provides data on the TiGenix NV’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates ...
May, 2013 52 pages... Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “Teijin Pharma Limited - Product Pipeline Review - 2013” provides data on the ... class, target and major milestones. Recent updates of the Teijin Pharma Limited’s pipeline in the last quarter. Key discontinued and dormant ...
May, 2013 50 pages... Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “Talon Therapeutics, Inc. - Product Pipeline Review - 2013” provides data on the ... stages of drug development, including the combination treatment modalities, across the globe. Product profiles for late stage and clinical stage ...
Apr, 2013 67 pages... . This report provides information on the therapeutic development for Proteinuria, complete with latest updates, and special features on late-stage and ... key players involved in the therapeutic development for Proteinuria. Proteinuria - Pipeline Review, Half Year is built using data and information sourced ...
May, 2013 37 pages... Market Direct’s pharmaceuticals report, “Plexxikon Inc. - Product Pipeline Review - 2013” provides data on the Plexxikon Inc.’s research and development focus. ... class, target and major milestones. Recent updates of the Plexxikon Inc.’s pipeline in the last quarter. Key discontinued and dormant projects. ...
May, 2013 46 pages... Market Direct’s pharmaceuticals report, “Oxagen Limited - Product Pipeline Review - 2013” provides data on the Oxagen Limited’s research and development focus. ... class, target and major milestones. Recent updates of the Oxagen Limited’s pipeline in the last quarter. Key discontinued and dormant projects. ...
May, 2013 27 pagesNicOx S.A. – Product Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “NicOx S.A. - Product Pipeline Review - 2013” provides data on the NicOx S.A.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates ...
May, 2013 64 pages... features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Neuroinflammation. Neuroinflammation - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University ...
May, 2013 45 pages... key players involved in the therapeutic development for Myotonic Dystrophy. Myotonic Dystrophy - Pipeline Review, Half Year is built using data and ... on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. Identify and ...
May, 2013 32 pages... reviews key players involved in the therapeutic development for Moderate Pain. Moderate Pain - Pipeline Review, Half Year is built using data and ... on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. Identify and ...
May, 2013 53 pages... key players involved in the therapeutic development for Mixed Dyslipidemia. Mixed Dyslipidemia - Pipeline Review, Half Year is built using data and ... on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. Identify and ...
May, 2013 46 pagesMimetogen Pharmaceuticals Inc. – Product Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “Mimetogen Pharmaceuticals Inc. - Product Pipeline Review - 2013” provides data on the Mimetogen Pharmaceuticals Inc.’s research and development focus. The report includes information on ...
May, 2013 25 pages... Market Direct’s pharmaceuticals report, “MethylGene Inc. - Product Pipeline Review - 2013” provides data on the MethylGene Inc.’s research and development focus. ... class, target and major milestones. Recent updates of the MethylGene Inc.’s pipeline in the last quarter. Key discontinued and dormant projects ...
Apr, 2013 86 pages... & Johnson – Product Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “Johnson & Johnson - Product Pipeline Review - 2013” provides data on the Johnson & Johnson’s research and development focus. The report includes information on current developmental pipeline, complete with ...
May, 2013 496 pages... . It also reviews key players involved in the therapeutic development for Intermittent Claudication. Intermittent Claudication - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, ...
May, 2013 68 pagesHospital Acquired Pneumonia (HAP) – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Hospital Acquired Pneumonia (HAP) - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Hospital Acquired ...
May, 2013 75 pages... reviews key players involved in the therapeutic development for Duodenal Ulcer. Duodenal Ulcer - Pipeline Review, Half Year is built using data and ... on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. Identify and ...
May, 2013 35 pages... key players involved in the therapeutic development for Chlamydia Infections. Chlamydia Infections - Pipeline Review, Half Year is built using data and ... on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. Identify ...
May, 2013 60 pages... projects. Latest news and deals relating to the products. Evaluate Bristol-Myers Squibb Company’s strategic position with total access to detailed ... . Identify new drug targets and therapeutic classes in the Bristol-Myers Squibb Company’s R&D portfolio and develop key strategic initiatives to reinforce ...
Apr, 2013 695 pages... Market Direct’s pharmaceuticals report, “BrainCells Inc. - Product Pipeline Review - 2013” provides data on the BrainCells Inc.’s research and development focus. ... class, target and major milestones. Recent updates of the BrainCells Inc.’s pipeline in the last quarter. Key discontinued and dormant projects ...
May, 2013 31 pagesAuspex Pharmaceuticals, Inc. – Product Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “Auspex Pharmaceuticals, Inc. - Product Pipeline Review - 2013” provides data on the Auspex Pharmaceuticals, Inc.’s research and development focus. The report includes information on ...
May, 2013 34 pages... licensing opportunities by identifying windows of opportunity to fill portfolio gaps. Exploit collaboration and partnership opportunities with Aurigene Discovery Technologies Limited. Avoid Intellectual Property Rights related issues. Explore the dormant and discontinued projects of Aurigene Discovery ...
May, 2013 47 pages... Global Market Direct’s pharmaceuticals report, “Arbovax, Inc. - Product Pipeline Review - 2013” provides data on the Arbovax, Inc.’s research and development focus. ... class, target and major milestones. Recent updates of the Arbovax, Inc.’s pipeline in the last quarter. Key discontinued and dormant projects ...
May, 2013 24 pages... reviews key players involved in the therapeutic development for Anterior Uveitis. Anterior Uveitis - Pipeline Review, Half Year is built using data and ... on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. Identify ...
May, 2013 42 pages... Pharma Gets US Patent For Vibex Injector Device Platform Apr 03, 2013: Antares Pharma Announces First Shipment Of Commercial Vibex Auto-Injector Devices To ... Milestone Payment From Pfizer This comprehensive SWOT profile of Antares Pharma, Inc. provides you an in-depth strategic SWOT analysis of the company’s ...
May, 2013 46 pages... from discovery till registration stages. A feature on pipeline projects on the basis of monotherapy and combined therapeutics. Coverage of the Paroxysmal Nocturnal Hemoglobinuria pipeline on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals ...
Apr, 2013 34 pagesNoven Pharmaceuticals, Inc. – Product Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “Noven Pharmaceuticals, Inc. - Product Pipeline Review - 2013” provides data on the Noven Pharmaceuticals, Inc.’s research and development focus. The report includes information on current ...
Apr, 2013 30 pages... reviews key players involved in the therapeutic development for Muscle Atrophy. Muscle Atrophy - Pipeline Review, Half Year is built using data and ... on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. Reasons to ...
Apr, 2013 29 pages... and featured press releases, both from Bioniche Life Sciences, Inc. and industry-specific third party sources, put together by Global Markets ... portfolio gaps. Exploit collaboration and partnership opportunities with Bioniche Life Sciences, Inc.. Avoid Intellectual Property Rights related issues. Explore ...
Apr, 2013 47 pagesAntisense Therapeutics Limited – Product Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “Antisense Therapeutics Limited - Product Pipeline Review - 2013” provides data on the Antisense Therapeutics Limited’s research and development focus. The report includes information on ...
Apr, 2013 57 pagesFirst Quantum Minerals Plans to Acquire Inmet Mining for $5.2 Billion – Deal Analysis from GlobalData Summary First Quantum Minerals Ltd., a mining ... Inmet Mining Corporation, a Canada-based global mining company. Scope The report provides a brief of First Quantum Minerals Ltd.'s plans to acquire all ...
Jan, 2013 7 pages... Revenue Of NOK480.9m In Q1 2012 Feb 14, 2012: Pronova BioPharma Reports Revenue Of NOK444.3m In Q4 2011 GlobalData’s Pronova BioPharma ASA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains ...
Apr, 2013 26 pages... from discovery till registration stages. A feature on pipeline projects on the basis of monotherapy and combined therapeutics. Coverage of the Percutaneous Coronary Intervention pipeline on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals ...
Apr, 2013 51 pages... reviews key players involved in the therapeutic development for Memory Impairment. Memory Impairment - Pipeline Review, Half Year is built using data and ... on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. Reasons ...
Apr, 2013 50 pages... and endocrinology among others. It is affiliated with Yale Schools of Medicine and Nursing and Yale Cancer Center and flagship member of the ... And Cigna Launch Collaborative Accountable Care Programn GlobalData’s Yale-New Haven Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into ...
Mar, 2013 22 pages... which it markets its products in more than 100 countries across the world. Richter Gedeon Nyrt. Key Recent Developments Feb 07, 2013: ... Reports Revenue Of €1.1 Billion In 2011GDPH29544FSA This comprehensive SWOT profile of Richter Gedeon Nyrt. provides you an in-depth strategic SWOT analysis of the company ...
Apr, 2013 44 pages... 22, 2012: OptumRx To Add 400 New Jobs In Arizona, USnFeb 15, 2012: OptumRx Receives URAC Specialty Pharmacy Accreditation GlobalData’s OptumHealth Care Solutions, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and ...
Mar, 2013 21 pages... for the treatment of epilepsy, pain and inflammation. GlobalData’s Neusentis - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s ... analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute company report will ...
Mar, 2013 20 pages... Limited Key Recent Developments Apr 12, 2012: ACLDT Reports Revenue Of SGD11m In H1 Fiscal 2012nGDPH297033FSA This comprehensive SWOT profile of Asian American Medical Group Limited provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by ...
Mar, 2013 28 pages... , and project management. It serves a wide range of markets such as heavy civil, commercial, industrial and institutional. GlobalData’s Angelo Iafrate Construction Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and ...
Mar, 2013 13 pages... the globe with operations in more than 60 countries. Actavis, Inc. Key Recent Developments Mar 08, 2013: Actavis To Close R&D Unit In Bulebel, Malta Feb 19, 2013: ... Reports Revenue Of $1.8 Billion In Q4 2012 Jan 24, 2013: Watson Pharma Adopts Actavis As New Global Name Dec 14, 2012: FTC Approves Final Order ...
Mar, 2013 50 pages... reviews key players involved in the therapeutic development for Cystic Fibrosis. Cystic Fibrosis - Pipeline Review, Half Year is built using data and ... on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. Reasons to ...
Apr, 2013 229 pages... reviews key players involved in the therapeutic development for Alcohol Addiction. Alcohol Addiction - Pipeline Review, Half Year is built using data and ... on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. Reasons ...
Apr, 2013 88 pages... reviews key players involved in the therapeutic development for Polycythemia Vera. Polycythemia Vera - Pipeline Review, Half Year is built using data and ... on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. Reasons ...
Mar, 2013 58 pages... Kidney Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ... on the basis of monotherapy and combined therapeutics. Coverage of the Polycystic Kidney Disease pipeline on the basis of route of administration and molecule type ...
Mar, 2013 60 pages... key players involved in the therapeutic development for Non-Hodgkin Lymphoma. Non-Hodgkin Lymphoma - Pipeline Review, Half Year is built using data and ... on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. Reasons to ...
Mar, 2013 493 pages... discovery till registration stages. A feature on pipeline projects on the basis of monotherapy and combined therapeutics. Coverage of the Mycobacterium Tuberculosis Infections pipeline on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals ...
Mar, 2013 253 pages
